Clinical Trials
7 trialsNCT06427941 2026-06-03
A Phase 1 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors
BeOne Medicines
Phase 1 Recruiting
NCT07513194 2026-04-07
GPC3 CAR T Cells With IL-15 and IL-21 for Recurrent ATRT and CNS Rhabdoid Tumors (RADIANT)
Baylor College of Medicine
Phase 1 Not yet recruiting
NCT06687941 2026-03-27
A Study to Evaluate the Tolerability, Safety, and PK of AST-201 in Patients With GPC3-positive Advanced Solid Tumors
Aptamer Sciences, Inc.
Phase 1 Recruiting
NCT04928677 2026-02-17
A Study of Codrituzumab in Children and Young Adults With Solid Tumors and Have Not Responded to Treatment or Have Come Back After Treatment
Memorial Sloan Kettering Cancer Center
Phase 1 Recruiting
NCT06478693 2025-12-18
A Study of MT-303 in Adults With Advanced or Metastatic GPC3-Expressing Cancers, Including HCC
Myeloid Therapeutics
Phase 1 Recruiting
NCT03198546 2024-06-25
GPC3-CAR-T Cells for Immunotherapy of Cancer With GPC3 Expression
Second Affiliated Hospital of Guangzhou Medical University
Phase 1 Recruiting
NCT04121273 2021-03-03
GPC3-targeted CAR-T Cell for Treating GPC3 Positive Advanced HCC
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 1 Unknown